Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMEG-ECDD: G-CSF vs peg-G-CSF in Localized Breast Cancer
NCT05296317Completed
- Sponsor
- Centre Georges-François Leclerc
- Start
- Sep 2022
- Primary completion
- Sep 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised trial in neutropenia comparing Arm 1: EC + G-CSF with Arm 2: EC + peg-G-CSF (2 arms). Primary endpoint: Variation of Neutrophils concentration at Day 8. Started Sep 2022; status: completed.
02
Drugs
filgrastimpegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT05296317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05296317.